OsciFlex is a pioneering brand that focuses on improving vascular health and preventing venous thromboembolism (VTE) through innovative products and services. Founded in 2017 by Dr. John Welsh and Dr.

Mark Kahn at the University of Pennsylvania, OsciFlex is driven by their groundbreaking research on the molecular pathways linking blood flow patterns to endothelial gene expression of thrombosis-related proteins. One of their remarkable achievements includes developing a unique protocol utilizing vascular ultrasound to analyze venous valve oscillatory flow in human subjects. This led to the creation of the initial OsciFlex device design, which has shown great potential in preventing VTE and treating post-thrombotic syndrome (PTS).

OsciFlex is committed to improving vascular imaging and has garnered recognition for its groundbreaking work. They have received grants from esteemed organizations like the National Science Foundation (NSF), the National Institutes of Health (NIH), and accolades such as the Penn Cardiovascular Institute Dream Team Award and the Penn Health Tech Award. For inquiries and more information on Osciflex's latest developments, reach out to them at their Pennovation Center address in Philadelphia or contact them via phone or email.

Stay updated by following them on LinkedIn to stay informed about their pioneering advancements in vascular health